ALLR — Allarity Therapeutics, Inc. catalysts
Next verified catalyst
2027-03-01 — Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovar · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Adv
Phase 2 · Advanced Ovarian Cancer |
ALLR Allarity Therapeutics, Inc. | 2X-121, 2X-121 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-01
Sponsor-projected date — can change
|